We present the case of a 70-year-old male patient with fever of unknown origin after a long period of convalescence from a previous admission to a chronic care hospital. During the admission, multiple combinations of antibiotic and antifungal treatments were prescribed, but with persistent fever and, eventually, neutropenia (200 lymphocytes, 0 neutrophils). Given the suspicion of infection at bone marrow level, a biopsy was performed as was serology of Leishmania, both diagnostic determinations. Treatment with amphotericin B liposomal resulted in a good outcome.
INTRODUCTION
Visceral leishmaniasis is a disease caused mainly by Leishmania donovani and Leishmania infantum. The main reservoirs in our environment are dogs, although mice and other wild animals can also transmit the flagellated protozoan through the bite of the female sandfly. In Spain, there have been relatively common outbreaks of Leishmania, such as that which occurred in the Community of Madrid between 2009 and 2012. Its incidence in our environment is 0.45 cases per 100,000 inhabitants. This is because the disease is present endemically in areas of the Mediterranean, more specifically in rural areas, mountain towns and peri-urban regions. 
DISCUSSION
Usually, Leishmania infection is asymptomatic, a consequence of the ability of the immune system to control parasitic replication. In Europe, only 1 in 30 people infected manifest the disease clinically, compared to 1 in 4 people in India, where the disease is endemic. This highlights the differences in virulence among several parasitic strains, genetic predisposition, nutritional status, age, and other factors. Subclinical infection can be evidenced in serological tests, and manifestations can appear before immunosuppression of the individual that contains the parasite in the phagocytic mononuclear system [1, 2] . The main clinical manifestation of visceral leishmaniasis is the syndrome known as kala-azar. The incubation period ranges from 2 to 6 months, with symptoms of insidious onset in the form of fever, weight loss, and splenomegaly with or without hepatomegaly. Patients may present with abdominal discomfort, especially in the left hypochondrium. The spleen can be palpated and usually is not painful [3] . Anaemia, neutropenia, eosinopenia, and thrombocytopenia are common in laboratory tests. The main methods to establish the diagnosis of infection include direct visualisation of the parasite in an extension of a tissue sample obtained by biopsy (bone marrow / spleen), culture in special media, and detection by polymerase chain reaction (PCR) of genetic material or serology. However, diagnostic certainty is made by direct observation of the parasite [1, 4, 5] . The treatment of first choice for visceral leishmaniasis is liposomal amphotericin B 3 mg/kg/day intravenously in immunocompetent patients and 4 mg/kg/day in immunosuppressed patients. Meglumine antimoniate can be used instead, or miltefosine or paromomycin sulfate as a second choice.
